Related Experiment Video
Updated: Jun 21, 2026

08:23
Single Cell Transcriptional Profiling of Adult Mouse Cardiomyocytes
Published on: December 28, 2011
Global gene expression profiling in the failing myocardium
Masanori Asakura1, Masafumi Kitakaze
1Department of Research and Development of Clinical Research, National Cardiovascular Center, Suita, Japan. masakura@hsp.ncvc.go.jp
Summary
New strategies identified novel genes linked to heart failure (HF) pathophysiology. Researchers found 107 HF-related genes, including extracellular molecules, offering potential diagnostic and therapeutic targets for heart failure.
Area of Science:
- Cardiology
- Molecular Biology
- Genomics
Background:
- Heart failure (HF) is characterized by reduced ventricular contraction and cardiac chamber dilation.
- Microarray analyses are commonly used to study gene expression in failing myocardium.
- Conventional methods compare limited sample pairs, potentially missing broader gene correlations.
Purpose of the Study:
- To identify novel genes associated with heart failure severity and pathophysiology.
- To explore new diagnostic and therapeutic targets for heart failure.
- To analyze comprehensive gene expression profiles in failing hearts.
Main Methods:
- Utilized novel approaches to identify genes strongly correlating with HF severity.
- Analyzed 7 independent microarray datasets to find consistently expressed HF-related genes.
- Investigated gene expression signatures in failing myocardium from dilated cardiomyopathy patients.
Main Results:
- Identified cardiac myosin light chain kinase (MLCK) as an HF-related gene.
- Revealed a 27-gene expression signature in dilated cardiomyopathy.
- Demonstrated 107 HF-related genes across multiple datasets, many linked to mitochondrial dysfunction.
- Highlighted periostin, pleiotrophin, and SERPINA3 as potential HF biomarkers.
Conclusions:
- Novel gene discovery strategies can identify key players in HF pathophysiology.
- Mitochondrial dysfunction and specific extracellular molecules are implicated in heart failure.
- Identified genes, including extracellular molecules, represent promising targets for HF diagnosis and treatment.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

